Small Molecules
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
1,205
NCT02090504
Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome
Phase: Phase 4
Role: Collaborator
Start: Feb 28, 2002
Completion: May 31, 2009
NCT02634515
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2014
Completion: Feb 28, 2015
NCT02631928
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III
Start: Feb 29, 2016
Completion: Jun 30, 2016
NCT02634528
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Start: Nov 16, 2016
Completion: Jan 20, 2017
NCT04577469
Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions
Start: Dec 31, 2020
Completion: Dec 31, 2020
NCT05497063
Bioequivalence Study of Sulfadoxine/ Pyrimethamine Dispersible Tablets in Healthy Subjects Under Fasting Conditions
Start: Dec 31, 2022
Completion: Feb 28, 2023
NCT07121868
Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations
Start: Aug 3, 2024
Completion: Jan 23, 2025
NCT06669052
Liposomal Iron 30 mg Supplement in Non-anemic Pregnant Females
Phase: N/A
Start: Nov 1, 2024
Completion: May 31, 2025
NCT07127094
Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations
Start: Mar 9, 2025
Completion: Jun 18, 2025
Loading map...